P2B001 site Chicago — Chicago, Illinois

P2B001 site Chicago is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

P2B001 site Chicago has participated in 1 clinical trials.

Therapeutic areas: Parkinson's Disease.

Sponsors: Pharma Two B Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for P2B001 site Chicago?

P2B001 site Chicago has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has P2B001 site Chicago conducted?

P2B001 site Chicago has 1 clinical trials on record. Their work covers Parkinson's Disease.

Is P2B001 site Chicago accredited by Crixeo Health?

P2B001 site Chicago has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about P2B001 site Chicago?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.